Centre approves increase in production of Remdesivir and reducing its prices

ED has been directed to act against black marketing of Remdesivir

The government has decided to increase the production and supply of Remdesivir and also to reduce its prices in the country. It has approved seven additional sites having a production capacity of 10 Lakh vials per month to six manufacturers.

The current total installed capacity of the seven manufacturers of Remdesivir in the country is 38 lakh 80 thousand vials per month. Minister of State for Chemicals and Fertilizers Mansukh Mandaviya today reviewed the issue of availability of Remdesivir in the country.

The Ministry said, another 30 lakh vials per month production is lined up. This will ramp up the production capacity for manufacturing to around 78 lakh vials per month. Earlier the government had prohibited exports of injection Remdesivir to increase the supply in the Domestic Market.


The Ministry said, manufacturers of Remdesivir have volunteered to reduce the price to less than 3,500 by the end of this week, to support the efforts to Fight against COVID. The manufactures have been directed to give priority to fulfil hospital and institutional level supplies.

Enforcement Authorities of States and Central Government have also been directed by Drugs Controller General of India, DCGI to take immediate action on the incidence of black-marketing, hoarding and overcharging of Remdesivir. The Ministry said National Pharmaceutical Pricing Authority is continuously monitoring the availability of Remdesivir.

Tags : #CentralGovernment #Remdesivir #DCGI #ED #EnforcementDiectorate #RemdesivirBlackMarketing

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Surviving Against the Odds: Steven Spinale's Journey After an Ingrown Hair Turns DeadlyMarch 29, 2024
10 reasons why media research and Planning are essential in Healthcare marketingMarch 29, 2024
The Surprising Link Between Sleep and Age Perception: What You Need to KnowMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 StudyMarch 29, 2024
Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024